Nova Patents
IS7490A

8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorderes

Abstract

This record has no abstract on file.

Term

Term ended

Projected expiry passed 6 October 2024, 2 years ago.

  1. Priority
  2. Filed and published
  3. Projected expiry
  4. Today

96 members in 29 offices

This recordMember, by publication datePriority claim19 more offices are in the list below

Priority claims16

Priority claims
DocumentOfficeKindDate
37205802United States of AmericaP
37205802United States of AmericaP
40549502United States of AmericaP
40549502United States of AmericaP
43460702United States of AmericaP
43460702United States of AmericaP
41099103United States of AmericaA
41099103United States of AmericaA
0311076United States of AmericaW
0311076United States of AmericaW
PCTUS2003011076–––
US20020372058P–––
US20020405495P–––
US20020434607P–––
US20030410991–––
WO2003US11076–––

Members96

Family members, oldest first
DocumentOfficeKind
CA2481723A1CanadaA1
WO03086306A2World Intellectual Property Organization (WIPO)A2
AU2003221866A1AustraliaA1
US2003225057A1United States of AmericaA1
TW200400037ATaiwan Province of ChinaA
WO03086306A3World Intellectual Property Organization (WIPO)A3
WO03086306B1World Intellectual Property Organization (WIPO)B1
EP1411881A2European Patent Office (EPO)A2
EP1411881A4European Patent Office (EPO)A4
IS7490AThis recordIcelandA
KR20040099426ARepublic of KoreaA
NO20044928LNorwayL
HK1064095A1Hong Kong, ChinaA1
US2005020573A1United States of AmericaA1
RU2004133068ARussian FederationA
BR0309303ABrazilA
CR7503ACosta RicaA
EP1411881B1European Patent Office (EPO)B1
AT294781TAustriaT
ATE294781T1AustriaT1
DE60300610D1GermanyD1
CN1646493AChinaA
EP1557409A1European Patent Office (EPO)A1
DK1411881T3DenmarkT3
PL373464A1PolandA1
JP2005527579AJapanA
MXPA04009965AMexicoA
PT1411881EPortugalE
US6953787B2United States of AmericaB2
SI1411881T1SloveniaT1
ES2242165T3SpainT3
IL164162D0IsraelD0
TWI252105BTaiwan Province of ChinaB
JP2006143751AJapanA
DE60300610T2GermanyT2
ZA200408506BSouth AfricaB
NZ535381ANew ZealandA
IS2134BIcelandB
EP1411881B9European Patent Office (EPO)B9
UA77788C2UkraineC2
US2007060568A1United States of AmericaA1
NO323528B1NorwayB1
GEP20074197BGeorgiaB
KR20080009340ARepublic of KoreaA
CA2481723CCanadaC
RU2317982C2Russian FederationC2
KR100812925B1Republic of KoreaB1
AU2003221866B2AustraliaB2
JP4155926B2JapanB2
CR10393ACosta RicaA
JP4191741B2JapanB2
JP2009001584AJapanA
KR20090007651ARepublic of KoreaA
US7514422B2United States of AmericaB2
CN100486967CChinaC
KR100908166B1Republic of KoreaB1
KR100908167B1Republic of KoreaB1
CN101485664AChinaA
CN101486677AChinaA
CN101486678AChinaA
CN101486679AChinaA
MY141476AMalaysiaA
US7977329B2United States of AmericaB2
EP2363394A1European Patent Office (EPO)A1
EP2374796A1European Patent Office (EPO)A1
JP2012006970AJapanA
PL396873A1PolandA1
PL211314B1PolandB1
PL211333B1PolandB1
US2012135982A1United States of AmericaA1
US8207158B2United States of AmericaB2
JP4966929B2JapanB2
US8273734B1United States of AmericaB1
US2012252788A1United States of AmericaA1
CN101486677BChinaB
US2013012495A1United States of AmericaA1
US2013012498A1United States of AmericaA1
JP2013018780AJapanA
US2013217676A1United States of AmericaA1
US8546379B2United States of AmericaB2
US8575149B2United States of AmericaB2
US8846906B2United States of AmericaB2
JP5602116B2JapanB2
US2015045552A1United States of AmericaA1
PL219017B1PolandB1
US8993750B2United States of AmericaB2
CN101486678BChinaB
US2016024014A1United States of AmericaA1
US2016250223A1United States of AmericaA1
EP2374796B1European Patent Office (EPO)B1
BRPI0309303B1BrazilB1
ES2670568T3SpainT3
PL231405B1PolandB1
BR122017023795B1BrazilB1
BRPI0309303B8BrazilB8
BR122017023795B8BrazilB8